April
Sanofi-aventis settles Eloxatin lawsuits
Sanofi-aventis has announced it has settled lawsuits with three companies regarding generic versions of colon cancer drug, Eloxatin
01 Apr 2010
GSK collaborates with Isis on rare diseases
GlaxoSmithKline has entered into a potential $1.5bn deal with Isis Pharmaceuticals to develop new drugs for rare and serious diseases
01 Apr 2010
More Eloxatin settlements for sanofi-aventis
S-A has announced a further three settlements with companies making generic versions of cancer drug, Eloxatin, following three last week
06 Apr 2010
Agreement to develop depression treatment
Marco Polo Pharmaceuticals and Biocortech are to develop BC-19 in treatment-resistant depression
06 Apr 2010
Nano-chip hope for oral cancer detection
Gently brushing a lesion on the tongue or cheek can help detect oral cancer, with success rates comparable to more invasive techniques
06 Apr 2010
Government's surplus vaccine deal with GSK
The UK's Department of Health has announced it has reached a deal with GlaxoSmithKline regarding outstanding orders of the swine flu vaccine
06 Apr 2010
ABPI announces full conference programme
The Association of the British Pharmaceutical Industry (ABPI) has announced the full agenda of its 2010 conference
06 Apr 2010
New appointment for ABPI's Scottish team
The Association of the British Pharmaceutical Industry has announced the appointment of Sandra Auld as operations director in Scotland
07 Apr 2010
Partnership to reach Chinese patients
Ireland-based ICON and China's Tigermed Consulting have signed an alliance agreement to improve access to Chinese patients
07 Apr 2010
BioAlliance Pharma and Therabel Group deal
Therabel Group is to pay BioAlliance Pharma for the European commercialisation rights to antifungal, Loramyc, and antiemetic, Setofilm
07 Apr 2010